Discharge prescribing of enteral opioids after initiation as a weaning strategy from continuous opioid infusions in the Intensive Care Unit

Authors

  • Bridgette Kram, PharmD, BCPS, BCCCP
  • Kylie M. Weigel, PharmD, BCPS
  • Michelle Kuhrt, PharmD
  • Daniel L. Gilstrap, MD

DOI:

https://doi.org/10.5055/jom.2018.0427

Keywords:

transitions of care, medication reconciliation, methadone, critical care, pain

Abstract

Objective: To evaluate the proportion of patients receiving a hospital discharge prescription for a scheduled enteral opioid following initiation as a weaning strategy from a continuous opioid infusion in the Intensive Care Unit (ICU).

Design: Retrospective, observational study.

Setting: Five adult ICUs at a large, quaternary care academic medical center.

Patients: Endotracheally intubated, opioid-naive adults receiving a continuous opioid infusion with a concomitant scheduled enteral opioid initiated. Exclusion criteria were receipt of fewer than two enteral opioid doses, documentation of a long-acting opioid as a home medication, the indication for the enteral opioid was not a weaning strategy, death during hospital admission or discharge to hospice.

Interventions: None.

Main outcome measures: The proportion of ICU and hospital survivors who received a discharge prescription for a scheduled enteral opioid, total duration of continuous opioid infusion, duration of continuous opioid infusion after initiation of an enteral opioid therapy, total duration of enteral therapy, ICU and hospital length of stay.

Results: Of 62 included patients, 19 patients (30.6 percent) received a new prescription for a scheduled enteral opioid at hospital discharge. The median duration of enteral opioid therapy was longer for patients who received a discharge prescription compared to those who did not (20.09 vs 8.89 days, p = 0.02), though the remaining endpoints were not different.

Conclusions: Utilizing scheduled enteral opioids as a weaning strategy from continuous opioid infusions may place patients at risk of ICU-acquired physical dependence on opioids.

Author Biographies

Bridgette Kram, PharmD, BCPS, BCCCP

Clinical Pharmacist, Department of Pharmacy, Duke University Hospital, Durham, North Carolina

Kylie M. Weigel, PharmD, BCPS

Clinical Pharmacist, Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts

Michelle Kuhrt, PharmD

Clinical Pharmacist, Department of Pharmacy, Duke University Hospital, Durham, North Carolina

Daniel L. Gilstrap, MD

Division of Pulmonology, Allergy, and Critical Care Medicine, Duke University Hospital, Durham, North Carolina

References

Barr J, Fraser GL, Puntillo K, et al.: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013; 41(1): 263-306.

Cammarano WB, Pittet JF, Weitz S, et al.: Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients. Crit Care Med. 1998; 26(4): 676-684.

Jacobi J, Fraser GL, Coursin DB, et al.: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002; 30(1): 119-141.

Bowens CD, Thompson JA, Thompson MT, et al.: A trial of methadone tapering schedules in pediatric intensive care unit patients exposed to prolonged sedative infusions. Pediatric Crit Care Med: J Society Crit Care Med World Federation Pediatric Intens Crit Care Societies. 2011; 12(5): 504-511.

Lugo RA, MacLaren R, Cash J, et al.: Enteral methadone to expedite fentanyl discontinuation and prevent opioid abstinence syndrome in the PICU. Pharmacotherapy. 2001; 21(12): 1566-1573.

Meyer MM, Berens RJ: Efficacy of an enteral 10-day methadone wean to prevent opioid withdrawal in fentanyl-tolerant pediatric intensive care unit patients. Pediatric Crit Care Med: J Society Crit Care Med World Federation Pediatr Intens Critl Care Societies. 2001; 2(4): 329-333.

Al-Qadheeb NS, Roberts RJ, Griffin R, et al.: Impact of enteral methadone on the ability to wean off continuously infused opioids in critically ill, mechanically ventilated adults: A case-control study. Annals Pharmacother. 2012; 46(9): 1160-1166.

Wanzuita R, Poli-de-Figueiredo LF, Pfuetzenreiter F, et al.: Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: A randomized controlled trial. Crit Care. 2012; 16(2): R49.

Battle CE, Lovett S, Hutchings H: Chronic pain in survivors of critical illness: A retrospective analysis of incidence and risk factors. Crit Care. 2013; 17(3): R101.

Cuthbertson BH, Roughton S, Jenkinson D, et al.: Quality of life in the five years after intensive care: A cohort study. Crit Care. 2010; 14(1): R6.

Dowdy DW, Eid MP, Sedrakyan A, et al.: Quality of life in adult survivors of critical illness: A systematic review of the literature. Intens Care Med. 2005; 31(5): 611-620.

Dowdy DW, Eid MP, Dennison CR, et al.: Quality of life after acute respiratory distress syndrome: A meta-analysis. Intens Care Med. 2006; 32(8): 1115-1124.

Hofhuis JG, Spronk PE, van Stel HF, et al.: The impact of critical illness on perceived health-related quality of life during ICU treatment, hospital stay, and after hospital discharge: A long-term follow-up study. Chest. 2008; 133(2): 377-385.

Pavoni V, Gianesello L, Paparella L, et al.: Outcome predictors and quality of life of severe burn patients admitted to intensive care unit. Scand J Trauma Resusc Emerg Med. 2010; 18: 24.

van der Schaaf M, Beelen A, Dongelmans DA, et al.: Poor functional recovery after a critical illness: A longitudinal study. J Rehabil Med. 2009; 41(13): 1041-1048.

Yaffe PB, Green RS, Butler MB, et al.: Is admission to the Intensive Care Unit associated with chronic opioid use? A 4-year follow-up of Intensive Care Unit survivors. J Intens Care Med. 2015; 32(7): 429-435.

Morandi A, Vasilevskis E, Pandharipande PP, et al.: Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. J Am Geriatr Soc. 2013; 61(7): 1128-1134.

Puntillo KA, Naidu R: Chronic pain disorders after critical illness and ICU-acquired opioid dependence: Two clinical conundra. Curr Opin Crit Care. 2016; 22(5): 506-512.

Szakmany T, Russell P, Wilkes AR, et al.: Effect of early tracheostomy on resource utilization and clinical outcomes in critically ill patients: Meta-analysis of randomized controlled trials. Br J Anaesth. 2015; 114(3): 396-405.

Paulson-Conger M, Leske J, Maidl C, et al.: Comparison of two pain assessment tools in nonverbal critical care patients. Pain Manag Nurs. 2011; 12(4): 218-224.

Drew BJ, Ackerman MJ, Funk M, et al.: Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010; 121(8): 1047-1060.

Nelson JE, Cox CE, Hope AA, et al.: Chronic critical illness. Am J Respir Crit Care Med. 2010; 182(4): 446-454.

Sjoding MW, Cooke CR: Chronic critical illness: A growing legacy of successful advances in critical care*. Crit Care Med. 2015; 43(2): 476-477.

Kahn JM, Le T, Angus DC, et al.: The epidemiology of chronic critical illness in the United States*. Crit Care Med. 2015; 43(2): 282-287.

Published

03/05/2018

How to Cite

Kram, PharmD, BCPS, BCCCP, B., K. M. Weigel, PharmD, BCPS, M. Kuhrt, PharmD, and D. L. Gilstrap, MD. “Discharge Prescribing of Enteral Opioids After Initiation As a Weaning Strategy from Continuous Opioid Infusions in the Intensive Care Unit”. Journal of Opioid Management, vol. 14, no. 1, Mar. 2018, pp. 35-42, doi:10.5055/jom.2018.0427.